Page last updated: 2024-08-16

potassium chloride and daunorubicin

potassium chloride has been researched along with daunorubicin in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kakishita, E; Sakamoto, K; Wakabayashi, I1
Masui, H; Sakamoto, K; Wakabayashi, I; Yoshimoto, S1
Giessler, C; Kang, W; Weiss, M1

Other Studies

3 other study(ies) available for potassium chloride and daunorubicin

ArticleYear
Potentiating effect of daunorubicin on vasocontractile responses to KCl and BAY K 8644 in rat aorta.
    The Journal of pharmacy and pharmacology, 1990, Volume: 42, Issue:10

    Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Aorta, Thoracic; Clonidine; Daunorubicin; Drug Synergism; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nifedipine; Phenylephrine; Potassium Chloride; Rats; Rats, Inbred Strains

1990
Daunorubicin-induced smooth muscle contraction: involvement of Ca2+ entry mechanism.
    The Journal of pharmacy and pharmacology, 1997, Volume: 49, Issue:9

    Topics: Animals; Antibiotics, Antineoplastic; Calcium; Calcium Channel Blockers; Daunorubicin; Guinea Pigs; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth; Muscle, Smooth, Vascular; Potassium Chloride; Trifluoperazine; Verapamil

1997
Effects of idarubicin and idarubicinol on rat coronary resistance and vasoconstrictor responsiveness of isolated aorta and mesentery.
    Anti-cancer drugs, 2006, Volume: 17, Issue:1

    Topics: Animals; Antibiotics, Antineoplastic; Aorta, Thoracic; Coronary Circulation; Daunorubicin; Dose-Response Relationship, Drug; Heart; Idarubicin; In Vitro Techniques; Inhibitory Concentration 50; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Potassium Chloride; Rats; Rats, Wistar; Vascular Resistance; Vasoconstriction; Vasoconstrictor Agents

2006